The Market Dynamics Advisory Group (MDAG) advises the Global Fund on policies and initiatives to improve its ability to shape markets of key health products. Its purpose is to ensure that the Global Fund’s buying power is leveraged to advance the development and manufacture of appropriate health products to combat the three diseases, taking into consideration price, quality, availability, and design.
This advisory body assumes the strategic and operational oversight roles of the former Market Dynamics and Commodities Ad-Hoc Committee (“MDC”) and the Affordable Medicines Facility-malaria Ad-hoc Committee (“AMFm”).
The MDAG reports to the Board through the Strategy, Investment and Impact Committee (SIIC) to enable alignment with the overall strategic direction of the Global Fund. It will ensure that the Board continues to receive high quality strategic advice on both market initiatives relevant to the Global Fund’s mandate, and innovative mechanisms that target improved access and impact at country level.
Contact | Report Fraud and Abuse | Legal | RSS | Sitemap
© 2013 The Global Fund to Fight AIDS, Tuberculosis and Malaria